Hereditary Testing Market

Report Code - ICT202297FZ | Industry - Information and Communications Technology | Published on - September, 2022 | Pages - 107 | Format -

Hereditary Testing Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)




Hereditary testing is a type of genetic testing that is used to identify genetic changes or mutations that are inherited from a parent or ancestor. It is used to diagnose genetic disorders and to identify individuals at risk for certain conditions. It can also be used to determine if a person is a carrier of a genetic disorder, or to determine a person's risk of developing a certain disorder.

Market Drivers

The key driving factors of the global Hereditary Testing market are:

  • Growing Prevalence of Genetic Disorders: The prevalence of genetic disorders is increasing due to the rise in the aging population and the increased awareness about these disorders. This is driving the demand for hereditary testing, as it helps to diagnose and treat these disorders.
  • Technological Advancements: Technological advancements such as next-generation sequencing and other advanced techniques have enabled the development of highly accurate and cost-effective tests for hereditary testing. This has led to an increase in the demand for hereditary testing.
  • Government Initiatives: Governments across the globe are taking initiatives to promote the use of genetic testing in order to reduce the burden of genetic diseases. This is driving the demand for hereditary testing.
  • Growing Awareness: Increasing awareness about genetic disorders and the availability of genetic tests is driving the demand for hereditary testing.
  • Increasing Healthcare Expenditure: Increasing healthcare expenditure is driving the demand for genetic testing, as it helps to diagnose and treat genetic disorders.

Market Challenges

  • Regulatory Framework: The global Hereditary Testing market is highly regulated and subject to stringent laws and regulations. In the US, the FDA regulates the sale of genetic tests and imposes strict requirements on companies wishing to market them. In Europe, the European Union has established a Genetic Testing Directive that sets out the criteria for the marketing of genetic tests. These regulations can be difficult to comply with and can be a major barrier to entry for new companies.
  • Technological Barriers: The technology used in genetic testing is complex and requires specialized equipment and expertise. This can be a major barrier for companies wishing to enter the market as the cost of developing and maintaining the necessary technology can be prohibitive.
  • Privacy and Data Protection: Genetic testing involves the collection and analysis of sensitive personal data, which can be a major concern for many consumers. Companies must ensure that they have adequate data protection measures in place to protect the privacy of their customers.
  • Cost: Genetic testing is often expensive and can be cost-prohibitive for many individuals. This can be a major barrier to the uptake of genetic testing, particularly in developing countries.
  • Ethical Issues: Genetic testing raises a number of ethical issues, such as the right to privacy and the potential for genetic discrimination. Companies must ensure that they are aware of and comply with relevant ethical guidelines.

The global hereditary testing market research report is a databook report that contains vital information on the hereditary testing market. Some of the prominent players in the market are Agilent Technologies, Inc., CENTOGENE, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd, Fulgent Genetic, Inc., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Medgenome, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, Sophia Genetics, Thermo Fisher Scientific, Inc., Twist Bioscience. The research report on the global hereditary testing market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.

Covid-19 Impact Analysis

The global economy is highly affected by the COVID-19. Various sectors in the economy are much affected by this pandemic. The global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the hereditary testing market. This report is helpful for business and industry practitioners. The study specifically intended to assist in explaining, directing, and understanding the potential of the hereditary testing markets. The study focuses on providing readers with an understanding of developments in the industry. The report also provides detailed insights on market segments, market forecasts, leading players, market drivers, and inhibitors.

Objectives of the Global Hereditary Testing Market Study

  • Define and discuss the global market for hereditary testing.
  • Analyze the various segments of the market as well as the market dynamics of hereditary testing.
  • Categorize hereditary testing segments with escalating growth potential and value the segments future market.
  • Analyze the key trends related to different segments and countries that help in figuring the hereditary testing market.
  • To check region-specific growth and development in the hereditary testing market.
  • Analyze the historical and current value of each of these product segments in the end-user and geographic markets.
  • Understand the foremost stakeholders of the market and the value of the competitive landscape of the leaders of the market.
  • To study the plans, initiatives, and strategies for the development of the market.

The second chapter, market overview, provides an overview of the hereditary testing market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.

Global Hereditary Testing Market Segmentation

Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments, year-on-year growth projections that enable readers to identify potential market growth areas.

  • Based on product type, the global hereditary testing market is segmented into hereditary cancer testing, hereditary non-cancer testing.
  • Based on application, the hereditary testing market is segmented into hospital, clinic, laboratory, others.

Global Hereditary Testing Market Regional Analysis

Chapter 4, the regional analysis includes an in-depth analysis of the hereditary testing market by region. The chapter includes various regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each years growth projections and a global share of value.

Global Hereditary Testing Market Competitive Analysis

Chapter 5, competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.

Global Hereditary Testing Market Company Profile

Chapter 6, the company profile of the report also covers key industry players working in the hereditary testing market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.

The study offers an exhaustive summary and estimate of the global market. It includes in-depth qualitative and quantitative analyses in the report that align with our customers goals and objectives. Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients to invest in the market based on the current business situation, trends, and potential developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into the global market, its products, and market patterns.

Scope of the Report

The global hereditary testing market has significant scope and provides a detailed description and evaluation of the market. It covers extensive qualitative and quantitative insights into the report that aligned with the goals and objectives of our intended customers.

Attribute Description
Base Year 2022
Historical Year 2019 - 2021
Forecast Period 2023 - 2029
Market Value US$ Million
Segments Covered

By Product Type: Hereditary Cancer Testing, Hereditary Non-cancer Testing.

By Application: Hospital, Clinic, Laboratory, Others.

Geographies Covered

North America: U.S., Canada

Europe: Germany, U.K., France, Italy, Spain, Russia, and the Rest of Europe

Asia Pacific: China, India, Japan, Australia, and Rest of Asia Pacific

The Middle East and Africa: GCC, South Africa and Rest of the Middle East and Africa

Latin America: Brazil, Mexico, and Rest of Latin America

Companies Agilent Technologies, Inc., CENTOGENE, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd, Fulgent Genetic, Inc., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Medgenome, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, Sophia Genetics, Thermo Fisher Scientific, Inc., Twist Bioscience

Sources of Information

The information in this research report was gathered using extensive primary research methodologies and supported secondary data-collection methods. As primary techniques, the interviews with key executives, managers, and industry professionals were conducted actively in the hereditary testing market. Secondary sources included published literature, investment reports, corporate literature, and various journals. Primary research validates secondary research information and industry trends to segment the market into several categories and generates an overall market size, markets forecast, and growth rate. That includes discussions with key industry leaders to confirm the facts. That allowed the closest possible figures to derive with no significant variations in the actual numbers.

The Following Key Questions are Addressed in this Hereditary Testing Market Report:

  • What is the size of the hereditary testing market?
  • What are some of the most recent trends that will shape the future of the hereditary testing market?
  • Who are the most important players in the hereditary testing market?
  • Which region has the greatest potential for growth in the hereditary testing market?
  • Which region has the largest share of the hereditary testing market?

1. Introduction

2. Market Overview

2.1. Global Hereditary Testing Market Introduction

2.2. Macro- Economic Factor

2.3. Market Determinants

2.3.1. Market Driver

2.3.2. Market Restraints

2.3.3. Market Opportunities

2.3.4. Market Challenges

2.4. Technology/Product Roadmap

2.5. PEST Analysis

2.6. Market Growth Opportunity Analysis

2.7. Impact of Covid-19 on Hereditary Testing Market

3. Market Segmentation

3.1. Global Hereditary Testing Market Analysis (US$ Mn), By Product Type, 2019 - 2029

3.1.1 Hereditary Cancer Testing

3.1.2 Hereditary Non-cancer Testing

3.2. Global Hereditary Testing Market Analysis (US$ Mn), By Application, 2019 - 2029

3.2.1 Hospital

3.2.2 Clinic

3.2.3 Laboratory

3.2.4 Others

4. Regional Analysis

4.1. North America Hereditary Testing Market Analysis (US$ Mn), 2019 - 2029

4.1.1. By Country

4.1.1.1. U.S.

4.1.1.2.Canada

4.1.2.By Product Type

4.1.3.By Application

4.2.Europe Hereditary Testing Market Analysis (US$ Mn), 2019 - 2029

4.2.1.By Country

4.2.1.1.Germany

4.2.1.2.U.K.

4.2.1.3.France

4.2.1.4.Italy 

4.2.1.5.Spain

4.2.1.6.Rest of Europe

4.2.2.By Product Type

4.2.3.By Application

4.3.Asia Pacific Hereditary Testing Market Analysis (US$ Mn), 2019 - 2029

4.3.1.By Country

4.3.1.1.China

4.3.1.2.Japan

4.3.1.3.India

4.3.1.4.Rest of Asia Pacific

4.3.2.By Product Type

4.3.3.By Application

4.4.Rest of world Hereditary Testing Market Analysis (US$ Mn), 2019 - 2029

4.4.1. By Region

4.4.1.1. Middle East & Africa

4.4.1.2. Latin America

4.4.2.By Product Type

4.4.3. By Application

5.Company Profiles 

5.1 Agilent Technologies, Inc.

5.2 CENTOGENE

5.3 CooperSurgical, Inc.

5.4 F. Hoffmann-La Roche Ltd

5.5 Fulgent Genetic, Inc.

5.6 Illumina, Inc.

5.7 Invitae Corporation

5.8 Laboratory Corporation of America Holdings

5.9 Medgenome

5.10 Myriad Genetics, Inc.

5.11 Natera, Inc.

5.12 Quest Diagnostics Incorporated

5.13 Sophia Genetics

5.14 Thermo Fisher Scientific, Inc.

5.15 Twist Bioscience

 

Request for Sample Report


Full Name
Company
Job Title/Designation
Business Email
Address
Country
Contact Number
Description
I acknowledge that I have read the Privacy Policy

Inquiry Before Buying


Full Name
Company
Job Title/Designation
Business Email
Address
Country
Contact Number
Description
I acknowledge that I have read the Privacy Policy

Speak to Analyst


Full Name
Company
Job Title/Designation
Business Email
Address
Country
Contact Number
Description
I acknowledge that I have read the Privacy Policy